Show simple item record

Treatment for amyloid A (AA) amyloidosis with eprodisate disodium (NC-503): 2-year results of efficacy and safety from a multi-center international trial

dc.contributor.authorGarceau, D.
dc.contributor.authorDember, L. M.
dc.contributor.authorBriand, R.
dc.contributor.authorHauck, W.
dc.contributor.authorDireskeneli, H.
dc.contributor.authorHazenberg, B. P.
dc.contributor.authorHawkins, P. N.
dc.contributor.authorButrimiene, I.
dc.contributor.authorLesnyak, O.
dc.contributor.authorLivneh, A.
dc.contributor.authorNasonov, E. L.
dc.contributor.authorFilipowicz-Sosnowska, A.
dc.contributor.authorMerlini, G.
dc.contributor.authorGul, A.
dc.contributor.authorWiland, P.
dc.date.accessioned2021-03-05T08:10:09Z
dc.date.available2021-03-05T08:10:09Z
dc.identifier.citationHazenberg B. P. , Hawkins P. N. , Butrimiene I., Lesnyak O., Livneh A., Nasonov E. L. , Filipowicz-Sosnowska A., Merlini G., Direskeneli H., Gul A., et al., "Treatment for amyloid A (AA) amyloidosis with eprodisate disodium (NC-503): 2-year results of efficacy and safety from a multi-center international trial", Annual European Congress of Rheumatology (EULAR 2006), Amsterdam, Hollanda, 21 - 24 Haziran 2006, cilt.65, ss.101
dc.identifier.othervv_1032021
dc.identifier.otherav_977e0dba-fddc-4fc1-bea5-25a0d042097e
dc.identifier.urihttp://hdl.handle.net/20.500.12627/101973
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectİmmünoloji ve Romatoloji
dc.subjectROMATOLOJİ
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.titleTreatment for amyloid A (AA) amyloidosis with eprodisate disodium (NC-503): 2-year results of efficacy and safety from a multi-center international trial
dc.typeBildiri
dc.contributor.department, ,
dc.identifier.volume65
dc.contributor.firstauthorID132576


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record